Bina Keshavan
Founder and Principal Consultant at Adagia Pharma Consulting LLC- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
Malayalam Native or bilingual proficiency
-
Tamil Native or bilingual proficiency
-
Hindi Native or bilingual proficiency
Topline Score
Bio
Tom Parry
I had the great pleasure of working with Bina during my tenure at Ovid Therapeutics. As head of our research and early development function, I was involved in both early- and late-stage development programs which Bina and her group oversaw. Bina's deep knowledge in drug discovery and development coupled with her ability management/staff development skills puts her at the top of program management leaders with whom I have worked. Her work ethic, communication and management skills are exceptional. I thoroughly enjoyed working with Bina and would highly recommend her to any team looking to discover and develop new therapeutics.
Tom Parry
I had the great pleasure of working with Bina during my tenure at Ovid Therapeutics. As head of our research and early development function, I was involved in both early- and late-stage development programs which Bina and her group oversaw. Bina's deep knowledge in drug discovery and development coupled with her ability management/staff development skills puts her at the top of program management leaders with whom I have worked. Her work ethic, communication and management skills are exceptional. I thoroughly enjoyed working with Bina and would highly recommend her to any team looking to discover and develop new therapeutics.
Tom Parry
I had the great pleasure of working with Bina during my tenure at Ovid Therapeutics. As head of our research and early development function, I was involved in both early- and late-stage development programs which Bina and her group oversaw. Bina's deep knowledge in drug discovery and development coupled with her ability management/staff development skills puts her at the top of program management leaders with whom I have worked. Her work ethic, communication and management skills are exceptional. I thoroughly enjoyed working with Bina and would highly recommend her to any team looking to discover and develop new therapeutics.
Tom Parry
I had the great pleasure of working with Bina during my tenure at Ovid Therapeutics. As head of our research and early development function, I was involved in both early- and late-stage development programs which Bina and her group oversaw. Bina's deep knowledge in drug discovery and development coupled with her ability management/staff development skills puts her at the top of program management leaders with whom I have worked. Her work ethic, communication and management skills are exceptional. I thoroughly enjoyed working with Bina and would highly recommend her to any team looking to discover and develop new therapeutics.
Credentials
-
Leadership in an Exponentially Changing World
MIT Sloan School of ManagementJun, 2021- Oct, 2024
Experience
-
Adagia Pharma Consulting LLC
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Founder and Principal Consultant
-
Mar 2022 - Present
-
-
-
Chief
-
Indonesia
-
Consumer Services
-
1 - 100 Employee
-
Member
-
Aug 2021 - Present
-
-
-
Ovid Therapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President, Head of Program Management
-
Jun 2017 - Apr 2022
– Established the function defining department vision, goals, best practices, and expansion plan. – Established and managed Governance committee to ensure organizational alignment on strategic and operational decisions on portfolio of products. – Collaborated with C-suite to establish portfolio strategies and setting and driving goals to deliver on that strategy. – Developed processes for portfolio review, program and corporate goals establishment, budget planning and set up program management tools, templates, and best practices including strategic products plans, stage gate contracts and integrated cross-functional project plans. – Optimized program-related communication through establishment of monthly pipeline reports for executives and quarterly communication to Board of Directors. – With a team of direct reports drove the setting of program strategy and its execution for late stage and early stage programs across various indications including Angelman syndrome, Fragile X syndrome, developmental epilepsies (Dravet syndrome, Lennox-Gastaut syndrome, Dup15q, CDKL5, TSC) and other neurodevelopmental disorders. – Co-Chair for Diversity, Equity, Inclusion and Belonging Council Show less
-
-
-
Shire
-
Japan
-
Biotechnology Research
-
700 & Above Employee
-
Senior Director, R&D Program Management TA Head
-
Apr 2016 - Jun 2017
Led team of 4 Program Managers to advance rare (MLD, Sanfillipo A, Hunter disease) and non-rare (ADHD, binge-eating disorder, status epilepticus), early-stage and marketed Neurology products Led team of 4 Program Managers to advance rare (MLD, Sanfillipo A, Hunter disease) and non-rare (ADHD, binge-eating disorder, status epilepticus), early-stage and marketed Neurology products
-
-
-
Biogen
-
South Africa
-
Wellness and Fitness Services
-
1 - 100 Employee
-
Head, External Scientific Communications
-
Oct 2015 - Apr 2016
Supervision of 25+ employees focused on publications, Congress management, thought leader and patient engagement and continuing medical education.
-
-
Senior Director, Program Leadership and Management
-
Mar 2001 - Sep 2015
Program management for early stage Immunology drug products to set strategy and achieve operational excellence. Program management to manage late stage (Phase 3 and marketed) Neurology products including in rare and non-rare indications to drive drive to registration and commercialization. 1 BLA/MAA filing and >10 Regulatory filingsDevelopmental products focused on indications in Multiple Sclerosis, ALS, Spinal Muscular Atrophy, Rheumatoid Arthritis, Idiopathic pulmonary fibrosis, Asthma, Lupus, congestive heart failure etc.Member of CEO's strategic initiative to improve processes, people and tools as the company scaled up Show less
-
-
-
PAREXEL
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Program Manager
-
1999 - Feb 2001
-
-
-
Ergoscience
-
Hospitals and Health Care
-
Scientist
-
1996 - 1999
Lead scientist focused on research on dopamine control of obesity and diabetes. Supervised a team of 2. Lead scientist focused on research on dopamine control of obesity and diabetes. Supervised a team of 2.
-
-
-
UC Irvine
-
United States
-
Higher Education
-
700 & Above Employee
-
Research Associate
-
1994 - 1996
-
-
Community
